Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treating socket discharge and discomfort: randomized test of vitamin A ointment, low-dose steroids and artificial tears
2023-504451-27-00Phase 4Withdrawn
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Bivalent/Multivalent Binders → Multivalent & Scaffold-Based Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Anophthalmic socket discharge and anophthalmic socket syndrome (ASS) comparing Artificial tears (Hylan sodium hyaluronate), Topical vitamin A ointment (retinol palmitate) and Low-dose topical steroid (FML Liquifilm fluorometholone) (3 arms). Primary endpoints: Change in discomfort score from baseline to 2 weeks and Change in discharge score from baseline to 2 weeks. Planned start Jun 2023; status: withdrawn.
02
Drugs
fluorometholoneLO2Aretinyl palmitate
03
Conditions
Anophthalmic socket dischargeanophthalmic socket syndrome (ASS)
Beyond the preview
Go deeper on 2023-504451-27-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-504451-27-00.